LENZ LENZ THERAPEUTICS
Health Care · Russell 2000
Next earnings: not announced yet
What 9 analyst firms say about LENZ THERAPEUTICS: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
8 rated views · 9 analyst/firm records · 9 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Fewer than 4 price targets in the last 6 months (3)
- Russell 2000 · Safest consensus · 6MNot scored · Fewer than 4 price targets in the last 6 months (3)
Recent analyst activity · last 90 days
Our tracked history has 12 reports on LENZ from 8 analyst firms in the last 90 days (9 firms in the past year).
Comparing each firm's latest target with its previous one: 2 lowered it and 2 have their first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: Citigroup lowered its target from $10.00 (set 12 Aug 2026) to $9.00 on 5 Nov 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Bank of America Securities | Jason Gerberry | Buy | 25 Mar 2026 | 29.00 USD |
| Citigroup | Yigal Nochomovitz | Buy | 12 Aug 2026 | 10.00 USD |
| H.C. Wainwright | Matthew Caufield | Buy | 30 Oct 2026 | Conflicting reports · excluded |
| Leerink Partners | Marc Goodman | Buy | 11 Aug 2026 | 10.00 USD |
| Piper Sandler | Biren Amin | Hold | 19 Oct 2026 | 5.00 USD |
| TD Cowen | Stacy Ku | Buy | 21 Oct 2026 | Conflicting reports · excluded |
| Weiss Ratings | Unnamed analyst | — | 9 Sep 2026 | — |
| William Blair | Lachlan Hanbury-Brown | Buy | 13 Oct 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 13 Aug 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 08:13 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.